Melcalin® MgK

Melcalin MgK thanks to its magnesium and potassium ratio contributes to the reduction of tiredness and fatigue, helps the normal functioning of the nervous and muscular system and contributes to a good psychological function.

Indice
    Add a header to begin generating the table of contents

    Description

    Melcalin MgK is a food supplement to dissolve in water made of magnesium and potassium in which the ratio of magnesium and potassium (1:4,8) was evaluated by measuring instrumentally (BIA-ACC BioTekna /in vivo neutron activation method IVANA / measure of K40) the recovery of the values of total potassium and of extracellular potassium on a sample of subjects with electrolyte disorders, medically unexplained symptoms (MUS) and related conditions.
    Magnesium is essential for the production of energy, the maintenance of electrolyte balance, for a correct neuromuscular function as well as for the homeostasis of calcium and potassium1,2,3,4,5,6: a magnesium deficiency is linked to a deficiency of potassium and calcium; therefore, its integration is also useful for healthy bones and teeth. Potassium intervenes in nerve transmission, in the regulation of the electrolyte balance, in the control of muscle contractility and arterial pressure7,8,9. It is therefore easy to notice the benefits of a combined supplementation of the two ions to all excitable tissues of the body (muscular, cardiovascular, nervous, gastrointestinal )10,11,12,13,14,15.

    Fields of application

    • It promotes proper electrolyte balance and homeostasis of magnesium, potassium and calcium.
    • It is useful in the presence of conditions affecting the excitable tissues:
      • muscle: chronic fatigue, loss of strength, cramps and fibromyalgia;
      • cardiovascular: arrhythmias and tachycardia;
      • gastrointestinal: bloating, acidity, digestive difficulties and gastric emptying, constipation and irritable bowel;
      • nervous: mood disorders, irritability, bipolarity, melancholy and depression.

    Bibliography

    1. Wien Med Wochenschr.1988 Aug 31;138(15-16):379-81. [Change in impulse formation and impulse transmission of the heart in relation to high magnesium concentration]. Stark G, Stark U, Pilger E.
    2. Am. J Ther. 2005 May-Jun;12(3):218-22. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias. Somberg JC, Cao W, Cvetanovic I, RanadeVV, Molnar J.
    3. Semin Nephrol. 1987 Sep;7(3):253-62. The relationship between disorders of K+ and Mg+ homeostasis.
    4. J Am Soc Nephrol 10: 1616–1622, 1999. Hypomagnesemia. Zalman S.Agus
    5. Lancet. 1998 Aug 1;352(9125):391-6. Magnesium and phosphorus. Weisinger JR, Bellorin-Font E.
    6. Am J Clin Nutr. 1987 May;45(5 Suppl):1305-12. Magnesium. Wester PO.
    7. Sidorov VY, Woods MC, Wikswo JP. Effects of elevated extracellular potassium on the stimulation mechanism of diastolic cardiac tissue. Biophys J. 2003 May;84(5):3470-9.
    8. Clin Endo crinol Metab. 1984 Jul;13(2):249-68. Potassium and the heart. Poole-Wilson PA.
    9. J Cardiovasc Electrophysiol. 2003 Dec;14(12):1351-5. Effects of elevated extracellular potassium ion concentration on anodal excitation of cardiac tissue.
    10. Gastrointestinal hypomotility in magnesium-deficient sheep L. Bueno, J. Fioramonti, E. Geux’z, and Y. RAISSIGUIER. Can. J. Anim. Sci. 60:293-301.
    11. F Clinical Nutrition (2008) 27, 25–concept for the treatment of gastrointestinal dysmotility in critically ill patients—status and future options Michael K. Herberta, Peter Holzerb.
    12. G Intestinal inflammation caused by magnesium deficiency alters basal and oxidative stress-induced intestinal function. , 59-69
    13. Magnesium.1988;7(2):78-83. Magnesium and inflammatory bowel disease. Galland L.
    14. Clin Chem. 1984 May;30(5):754-7. Relationship of potassium and magnesium concentrations in serum to cardiac arrhythmias. Boyd JC, Bruns DE, DiMarco JP.
    15. Council of the european union. 27 jannuary 2012

    Supplements with common fields of application

    Newsletter

    Enter your e-mail to keep up to date on Melcalin® products

    Newsletter

    Enter your e-mail to keep up to date on Melcalin® products

    melcalin-logo

    MELCALIN® IS A LINE OF FOOD SUPPLEMENTS SPECIFICALLY DESIGNED FOR THE RECOVERY OF THE ACID-BASE BALANCE, OF THE METABOLIC AND NEUROIMMUNOENDOCRINE FUNCTIONALITIES, FOR THE RECOVERY OF VAGA AND ASPECIFIC SYMPTOMS (MUS) AND THE ACHIEVEMENT OF PSYCHOYS

    melcalin-logo

    MELCALIN® IS A LINE OF FOOD SUPPLEMENTS SPECIFICALLY DESIGNED FOR THE RECOVERY OF THE ACID-BASE BALANCE, OF THE METABOLIC AND NEUROIMMUNOENDOCRINE FUNCTIONALITIES, FOR THE RECOVERY OF VAGA AND ASPECIFIC SYMPTOMS (MUS) AND THE ACHIEVEMENT OF PSYCHOYS

    PRODUCED BY BIOTEKNA © – BIOMEDICAL TECHNOLOGIES

    Melcalin® is a registered trademark of BioTekna © | Biomedical Technologies | VAT number 01307750933

    All rights reserved 1996 – 2022